Calendar Daxor Corporation Nyse

Equities

DXR

US2394671034

Market Closed - Nyse 16:30:00 2024-04-26 EDT 5-day change 1st Jan Change
9.65 USD 0.00% Intraday chart for Daxor Corporation -0.92% +0.52%

Chart calendar Daxor Corporation

1f021b537584f389a0cb8e3fb.OIHcl1m1kh3GeqZaeze7DNf0nNbNg5qlcr4X0MzEp3E.UuXkoBDqp0-LA8s3T3LsdYeC_7u-2t3sFshnvIGL0CRXwuzyL9LNLb9C6w~2a23a9c6b7092203d242f6da14591761

Upcoming events on Daxor Corporation

2024-08-21 Q2 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)
2025-08-20 Q2 2025 Earnings Release (Projected)
2026-02-25 Q4 2025 Earnings Release (Projected)

Past events on Daxor Corporation

2024-04-17 MedAxiom CV Transforum Spring Conference
2024-04-05 American College of Cardiology Scientific Meeting
2024-03-25 16:00 Q4 2023 Earnings Call
2024-03-18 14:18 Q4 2023 Earnings Release
2024-03-03 Technology and Heart Failure Therapeutics Conference
2024-01-31 Society of Nuclear Medicine and Molecular Imaging Mid Winter and American College Nuclear Medicine M
2024-01-20 Society for Critical Care Medicine Congress
2023-10-07 Heart Failure Society of America Meeting
2023-10-07 Heart Failure Society Scientific Conference
2023-10-05 Heart Failure Society Scientific Meeting - Poster #339
2023-10-04 MedAxiom CV Transforum Fall Conference
2023-09-11 07:00 H.C. Wainwright Global Investment Conference
2023-06-28 American Association of Heart Failure Nurses Meeting
2023-06-21 15:30 Maxim Group Virtual Healthcare Conference
2023-04-19 MedAxiom CV Transforum Spring Conference
2023-04-18 International Society for Heart and Lung Transplant Meeting - Poster #117.532
2023-04-18 International Society for Heart and Lung Transplant Meeting - Poster #116.531
2023-04-18 International Society for Heart and Lung Transplant Meeting - Poster #118.537
2023-03-19 Technology Heart Failure Therapeutics Conference
2023-03-02 09:00 Q4 2022 Earnings Call

Past dividends on Daxor Corporation

2018-01-04 Annual 0.03 USD
2016-12-19 Annual 0.03 USD
2015-12-17 0.04 USD
2014-12-03 0.03 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million USD
Released
Forecast
Spread
0,38
0,39
-3.5%
0,26
3,50
-92.44%
0,28
0,13
120.71%
EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,60
-
0,00
0,00
-
EBIT
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-0,50
0,21
-332.47%
0,00
0,00
-
4,75
-1,55
406.93%
Net income
Million USD
Released
Forecast
Spread
-0,50
0,32
-254.89%
0,00
0,00
-
4,75
-1,55
406.53%
EPS
USD
Released
Forecast
Spread
-0,13
0,08
-265.38%
-0,42
0,15
-381.33%
0,00
0,00
-
Announcement Date28/02/2025/02/2128/02/22

Quarterly results

Fiscal PeriodDecember 2021 S1
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,55


Net income
Million USD
Released
Forecast
Spread
-1,55


Announcement Date30/08/21

Net sales - Annual - Rate of surprise